Helice Genomic Sciences, Inc

Helice is a platform that connects physicians and individuals to genomics laboratories based abroad and provides them a portfolio of the latest genomics-based tests and assays to arm them with powerful and actionable options for navigating the right medical care for the patient’s individual needs. Helice has four categories of genomic testing products. First is SOLID TUMOR GENETIC PROFILING tests that detect genomic alteration in the cancer tumor itself. The second is PHARMACOGENOMICS, a test that looks at genetic variants in the patient, the presence of which may have the potential to affect drug absorption, metabolism and activity. The third category is LIQUID BIOPSY test. Using a blood sample, the test can quantitatively detect cancer-driving gene variants and drug resistance markers. WELLNESS SCREENING tests offer healthy adults, who may or may not have a strong personal or family history of disease, an opportunity to learn about how their genes could potentially impact their health and focus on prevention. Helice believes that the future of personalized healthcare is genomics. And we are bringing this to you right here, right now. Let us help you.